Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

ItalyBack to Italy

Clinical trials in Vizzolo Predabissi (MI)

2 clinical trials in Vizzolo Predabissi (MI), Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Vizzolo Predabissi (MI) at a glance
2
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 trials in Vizzolo Predabissi (MI)

Open in trial search

Heart failure with preserved ejection fraction

Recruiting
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB

Chronic prostatitis/chronic pelvic pain syndrome

Not yet recruiting
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Botulinum Toxin Type A
  • Sponsor:Ospedale San Raffaele S.r.l.

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Vizzolo Predabissi (MI)

What the registry says about research in the country

01 Vizzolo Predabissi (MI)
Analytical, Diagnostic and Therapeutic Techniques and Equipment
In Vizzolo Predabissi, researchers are testing a novel injection approach to relieve pain in adults with chronic pelvic pain syndrome. The study evaluates how targeted delivery of a neurotoxin into pelvic floor muscles can improve patient comfort. botulinum toxin A therapy pelvic floor muscle injection techniques pain reduction outcomes patient-reported quality of life The trial aims to add a new therapeutic tool for managing persistent pelvic pain and could expand treatment options for both men and women.
Cardiovascular Diseases
A separate recruiting study in the same city examines the impact of elecoglipron on adults with heart failure with preserved ejection fraction or mildly reduced ejection fraction, seeking to lower cardiovascular death and urgent heart‑failure visits. elecoglipron efficacy heart failure with preserved ejection fraction cardiovascular mortality reduction urgent heart‑failure visit prevention Conducted alongside background SGLT2 inhibitor therapy, the research could reshape management strategies for patients with advanced heart failure.
Reproductive and Urinary Physiological Phenomena
The chronic pelvic pain syndrome trial also addresses the broader urinary and reproductive implications of the condition, integrating diagnostic assessments with therapeutic interventions. chronic pelvic pain syndrome diagnostics urinary symptom evaluation reproductive health impact multidisciplinary treatment approaches Findings are expected to enhance understanding of pelvic disorders and improve care pathways for affected patients.
Back to ItalyAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.